Advertisement

Reactions Weekly

, Volume 1182, Issue 1, pp 19–19 | Cite as

Hydroxycarbamide/imatinib

Myelosuppression: 4 case reports
Case report
  • 9 Downloads

Keywords

Neutropenia Platelet Count Thrombocytopenia Congenital Anomaly Tumour Progression 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

REFERENCE

  1. 1.
    Shah GD, Silver JS, Rosenfeld SS, Gavrilovic IT, Abrey LE, Lassman AB.Myelosuppression in patients benefiting from imatinib with hydroxyurea for recurrent malignant gliomas. Journal of Neuro-Oncology 85: 217-222, No. 2, Nov 2007 - USAGoogle Scholar

Copyright information

© Adis International limited or Adis Data Information BV 2007

Personalised recommendations